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Abstract 
Purpose: To develop a new analytical method for the quantitative analysis of miconazole nitrate (MCN) 
and hydrocortisone (HCA) in pharmaceutical creams.  
Methods: The study was accomplished in three steps. In the first stage, a spectroscopic method was 
developed for the simultaneous analysis of miconazole (MCN) and hydrocortisone (HCA). For this 
purpose, serial dilutions of both drugs were prepared using ethanol: water (50:50) as the solvent 
system. All solutions were analyzed for absorbance spectrophotometrically at 205 and 249 nm for MCN 
and HCA, respectively. The method was validated for linearity, range, accuracy, precision and 
robustness. A commercial formulation was also assayed by the proposed method.  
Results: The absorbance data were linear over a concentration range of 1 to 12 µg/mL for MCN and 1 
to 40 µg/mL for HCA, with correlation coefficient of 0.9995 and 0.9984, respectively. Limit of detection 
(LOD) and of quantification (LOQ) of MCN were 0.49 and 1.49 µg/mL, respectively, and for HCA, 1.50 
and 4.57 µg/mL, respectively. The assay results for the commercial formulation were within the limits 
specified in British Pharmacopoeia.  
Conclusion: Simultaneous quantification of miconazole (MCN) and hydrocortisone (HCA) by UV 
spectroscopy provides a simple, reliable and robust method for the characterization of a mixture of the 
drugs in a dosage form. 
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Synergistic combinations of different drugs are 
frequently prescribed for the treatment of 
complex pathologic conditions [1]. Formulations 
are also designed for such combinations as they 
improve patient compliance and to reduce cost of 
treatments. Complexity in the formulation 
requires modification of the analytical method. 
There are numerous literature evidences to 
demonstrate the analysis of drugs from 
combination dosage forms. These emphasize 
either separation of individual components or 
simultaneous analysis by using different 
advanced analytical methods such as high 
pressure liquid chromatography (HPLC) [2-4] 
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Gas chromatography [5-7] HPTLC [8,9], 
fluoromertric method [10], micellar electrokinetic 
chromatographic method [11], bioanalytical 
method [12], photochemical reaction [13] and 
voltametric methods [14]. Although these 
techniques are reported with improved sensitivity 
for the measurement of the minute quantities of 
medicines in a dosage forms, these techniques 
are expansive to install and requires a higher 
degree of operator skill.  
 
Pharmaceutical analysts frequently desire 
simpler methods for the quantification of 
medicines from dosage forms containing two or 
more substances [15]. As a bench marks of 
batch reproducibility, it is desirable to perform a 
faster analysis of the active pharmaceutical 
ingredients at in process stage or after final 
formulation. One such approach is development 
of analytical method for the quantification of 
combination dosage form using UV-visible 
spectrophotometer. Since this tool is well 
established, economical and simple, extension of 
its application will be of great benefit to analysts 
[16].  
 
Miconazole nitrate is an antifungal agent which 
belongs to chemical class of imidazoles, having 
molecular formula C18H14Cl4N2O [17]. It shows in-
vitro activity against dermatophytes (e.g., 
Epidermophyton floccosum, Trichophyton 
mentagrophytes), some actinomycetes (e.g., 
Streptomyces madurae, Nocardia asteroides), 
and yeasts (e.g., Candida albicans, Pityrosporum 
orbiculare and pachydermatis, Cryptococcus 
neoformans). It also shows activity against some 
anaerobic and Gram positive bacteria (e.g., 
Staphylococcus aureus, Streptococcus faecalis, 
Bacteroides fragilis) [18]. Oral gel and tablets of 
miconazole are used to treat oral candidiasis. 
 
Hydrocortisone acetate also known as (11 β)-
pregn-4-ene-3, 20-dione,11, 17, 21-trihydroxy 
with a chemical formula of C21H30O5, is a 
naturally occurring glucocorticoid hormone, 
which has many physiological effects i.e. 
intermediary metabolism regulation, 
cardiovascular function, immunity and growth. It 
is bound to corticosteroid binding globulin (CBG) 
which is an alpha-2 globulin produced by liver. 90 
% of hydrocortisone is bound to it during normal 
conditions. 5 - 10 % of hydrocortisone is free or 
bound to albumin to exert its action on target 
cells [17]. Miconazole nitrate 2 % w/w and 
hydrocortisone acetate 1 % w/w are used in 
combination topically to treat various skin 
infections e.g. athlete’s foot and candidal 
intertrigo [19]. 
 
Despite the fact that these two medicines (MCN 
and HCA) are co-formulated as topical 
preparation, no ultraviolet-visible spectroscopy-
based analytical method was found in the 
literature. The aim of this study was to develop 
an ultraviolet spectroscopy based method for the 
simultaneous determination of MCN and HCN in 






Miconazole nitrate (MCN) and hydrocortsione 
(HCN) were received as a gift from Fassgen 
Pharmaceuticals Private Limited, Islamabad, 
Pakistan. All the other chemicals used including 
ethanol, methanol, hydrochloric acid and sodium 
hydroxide were of analytical grade. Two 
marketed creams containing MCN and HCA 
were purchased from a local pharmacy in 
Islamabad, Pakistan. 
 
Preparation of standard solutions 
 
Standard solutions of each drug were prepared 
in three different solvents namely 0.1 N HCl, 0.1 
N NaOH and 50 % ethanol. For this purpose, 1 
% w/v stock solutions of MCN and HCA was 
prepared by dissolving 1 g of each drug in the 
given solvent (100 mL q.s). These solutions were 
sonicated for 5 minutes to ensure a complete 
dissolution of the drug substances and labeled 
as stock solutions. A further dilution of the stock 
solutions (to 0.01 %v/v, i.e., 1:100) was made to 
obtain a working standard of 100 µg/mL 
concentration of the drug. 
 
Determination of lambda maximum (λmax) 
 
For the determination λmax of both drugs, 
ethanoic solutions containing 10 µg/mL of each 
drug were scanned over a wavelength range of 
200 nm to 400 nm using Jasco UV-Visible 
spectrophotometer (Double beam, Model: Jasco 
V-530, equipped with quartz cuvettes of path 
length 1cm) by using 50 % ethanol as blank. The 
overlay spectra of both drugs are shown in 
Figure 1. 
 
The wavelengths showing maximum absorbance 
(λmax) at 205 and 249 nm for MCN and HCA, 
respectively were used for the development and 
validation of method for simultaneous 
quantification of subject drugs. 
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Figure 1: UV-Visible spectra of MCN and HCA 
 
Determination of linear range 
 
Linearity of the method was determined by using 
four different series of solutions of both drugs 
named as series 1 to 4. Series 1 and 2 includes 
separate solutions of MCN and HCA ranging 
from 1 to 12 µg/mL and 1 to 40 µg/mL, 
respectively. While series 3 and 4 were binary 
solutions containing combination of drugs in 
different ranges i.e. in series 3 the concentration 
of HCA was kept constant (10 µg/mL) while the 
concentration of MCN was increased from 1 to 
12 µg/mL. In the series 4, the concentration of 
MCN was kept constant (10 µg/mL) while the 
concentration of HCA was increased from 1 to 40 
µg/mL. All the above prepared dilutions were 
analyzed at the maximum wavelengths (λmax) for 
each drug as described above. In all the cases, 
ethanol (50 % w/v) was used as blank.  
 
Determination of LOD, LOQ, Precision, 
accuracy and robustness of the analytical 
method 
 
Limit of detection (LOD) and limit of quantification 
(LOQ) of the both drugs were determined by the 
formula as shown in Eq 1 and 2, respectively. 
LOD refers to the lowest concentration of drug 
which can be detected reliably. At this 
concentration the signals are well differentiated 
from the noise levels (signal to noise ration 3:1). 
LOQ is the lowest amount of drug that can be 
measured with appropriate precision and 
accuracy. At LOQ the signal to noise ratio is 
10:1. 
  
 ……………………… (1) 
 ……………………. (2) 
 
where SD is standard deviation at low 
concentration and b is slope of calibration. The 
accuracy of this method was ascertained by 
determining the percentage recovery of drug(s) 
from all the standard solutions with known drug 
concentrations. The precision was determined in 
terms of intra-day precision (repeatability), inter-
day precision (intermediate precision) and 
precision between laboratories (reproducibility). 
The study was performed at three concentration 
levels and for each concentration, five replicate 
were used for the test. 
 
Robustness, ability of the method to remain 
unaffected by small change in the method, was 
determined by recording absorbance of a sample 
at slightly different temperature and pH. 
 
Application of validated method to physical drug 
mixture and commercial cream  
 
In the second stage of study the validated 
method was tested on the physical mixture of 
both drug and on a commercial topical cream. 
Physical mixture containing 20 and 10 mg of 
MCN and HCA, respectively was prepared and 
analyzed by using at λmax of respective drugs. 
The average absorbance data from five 
observations were used for the precise 
determination of drug contents in the solution. 
 
Commercial topical cream containing 2 and 1 % 
w/w of MCN and HCA was used to test the 
developed method. For this, purpose 1.0 g of the 
cream was dissolved in 100 ml ethanol 50 %. 
The solution was filtered through Whatman filter 
paper after sonication of 5 min. The filtrate was 
further diluted (to 1:20) using the same solvent to 
make a second dilution containing MCN and of 
HCA at concentration of 10 and 5 µg/mL, 
respectively. The absorbance (A) of both the 
samples was measured at the λmax of both the 
drugs using 50% ethanol as blank solution. The 
percent contents of each drug were calculated 
using Eqs 3 and 4.  
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MCN (%) = (At/As)100 …………………. (3) 
 
where At and As are the absorbance of test and 
standard samples, respectively at 205 nm. 
 
HCA (%) = (At/As)100 …………………. (3) 
 
where At and As are the absorbance of test and 
standard samples, respectively at 249 nm. 
 
Data analysis was carried out for the 
determination of accuracy, linearity, precision, 
mean, standard deviation, relative standard 
deviation, percent recovery and robustness by 






The calibration curves obtained from the four 
sets of solutions (namely 1 to 4) are shown in 
Figure 2.  The absorbance data of MCN, 
recorded at 205 nm, with increasing 
concentrations (up to 12 µg/ml) showed a linear 
correlation R2 = 0.999 for both types of solutions 
containing MCN alone and in combination with 
HCA. Similarly, the absorbance data of HCA, 
recorded at 249 nm, with increasing 
concentrations (up to 40 µg/ml) showed a linear 
correlation R2 = 0.9998 for both types of solutions 
containing HCA alone and in combination with 
MCN. This trend confirms that the absorbance 
profiles for both drugs (either alone or in 
combination) follow the Beer Lambert law [20], 
suggesting that the absorbance is proportional to 
the concentration of the respective analytes.  
 
The extinction coefficient’s value from this study 
was in good agreement with the one described in 
literature which in essence proves the validity of 
the method. 
 
Other parameters of equations describing the 
linear function i.e. slope and intercept showed an 
increase in their values from 0.0639 to 0.1394 
and 0.0103 to 0.1095, respectively for MCN. The 
absorbance data of hydrocortisone in binary 
solution, on the other hand, have shown no 
change in the values of slope and differ from the 
test solution in terms of its intercept value; the 
former being elevated to 0.2523 from 0.2190. 
 
Limit of detection and of quantification 
 
Limit of detection (LOD) and of quantification 
(LOQ), were determined as a part of validation 
protocol on the prescribed analytical method. For 
binary solutions of MCN and HCA (latter at fixed 
concentration), LOD and LOQ values for MCN 
were calculated as 0.4944 µg/mL and 1.4938 
µg/mL, respectively. Similarly, LOD and LOQ for 
binary solutions containing HCA and MCN (latter 
at fixed concentrations) for HCA were found to 





Figure 2: Calibration curves of (A) MCN, (B) HCA, (C) MCN in the presence of HCA and (D) HCA in 
the presence of MCN 
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The accuracy studies were performed by 
determining the percentage recovery of drug(s) 
from all the solutions containing individual drug 
substance as well as from binary solutions. The 
percentage recovery for all the solutions were 
found to be in the range of 99 – 102 %. The 
results for these studies are summarizes in Table 




The precision of this analytical procedure was 
determined in terms of intra-day precision 
(repeatability), inter-day precision (intermediate 
precision) and precision between laboratories 
(reproducibility). These studies were performed 
at three levels of drug concentrations (i.e., 6, 8, 
10 µg/mL and 5, 10, 15 µg/mL for MCN and 
HCA, respectively) and for each concentration 
the absorbance was recorded as five replicates. 
The results are described in terms of 




The robustness of the method was established 
from the changes in λmax in response to slight 
changes in temperature and pH. The λmax for 
both drug was largely unaffected by changes in 
temperature 25 ± 3 °C. Figure 3 A and B shows 
changes in the position of λmax of MCN and HCA, 
respectively. The λmax of HCA was persistent in 
both acidic (0.1 N HCl) and alkaline (0.1 N 
NaOH) conditions. In the case of MCN, λmax was 
least affected in acidic pH, however, 
bathochromic shift was observed at higher pH 
conditions (i.e., 0.1 N NaOH). The above results 
suggest that this approach is fairly robust in 
terms of thermal changes and decrease in pH. 
 
Table 1: Recovery and accuracy of MCN alone and in binary (MCN + HCA, the latter in fixed concentration) 




















12 0.7788 ± 0.010 12.03 ± 0.03 100.22 ± 1.02 1.7802 ± 0.012 11.9849 ± 0.13 99.87 ± 1.03 
10 0.6419 ± 0.008 9.88 ± 0.12 98.84 ± 0.99 1.4898 ± 0.0078 9.9017 ± 0.27 99.01 ±1.4 
8 0.523 ± 0.01 8.02 ± 0.05 100.29 ± 1.05 1.2256 ± 0.010 8.0064 ± 0.19 100.08 ±1.08 
6 0.3955 ± 0.007 6.03 ± 0.15 100.46 ± 1.11 0.9673 ± 0.0071 6.1535 ± 0.08 102.55 ±2.01 
4 0.2722 ± 0.001 4.10 ± 0.05 102.46 ± 1.81 0.6768 ± 0.0057 4.0695 ± 0.11 101.73±2.05 
 
Table 2: Recovery and accuracy results of HCA alone or in binary (HCA + MCN, the latter in fixed concentration) 



















Mean  accuracy (%) 
15 0.8108 ± 0.013 14.80 ± 0.23 98.74 ± 1.3 0.6661 ± 0.014 9.8056 ±0.02 98.05 ±0.97 
20 1.0118 ± 0.01 19.78 ± 0.05 98.87 ± 0.99 1.1119 ±0.17 20.3696 ±0.016 101.84 ±1.15 
25 1.2156 ± 0.03 24.81 ± 0.04 99.22 ± 1.43 1.3184 ±0.084 25.2630 ±0.024 101.05 ±1.21 
30 1.4465 ± 0.012 30.51 ± 0.12 101.69  ± 1.6 1.5303 ±0.055 30.2843 ±0.03 100.94 ± 1.47 
35 1.6503 ± 0.01 35.54 ± 0.03 101.54 ± 1.49 1.7295 ±0.12 35.0047 ±0.19 100.± 0.9701 
 



















MCN 6 6.11 ± 0.08 1.43 6.01 ± 0.10 1.75 5.94 ± 0.03 0.65 
8 7.98 ± 0.08 1.06 7.98 ± 0.06 0.75 7.93 ± 0.08 1.06 
10 10.62 ± 0.12 1.20 10.67 ± 0.11 1.10 10.54 ± 0.08 0.84 
HCA 5 5.10 ± 0.08 1.70 4.98 ± 0.03 0.79 5.07 ± 0.06 1.23 
15 14.99 ± 0.14 0.96 15.36 ± 0.21 1.40 15.45 ± 0.27 1.79 
25 25.41 ± 0.31 1.25 24.93 ± 0.18 0.73 26.11 ± 0.51 1.97 
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Figure 3: UV-visible spectra in the range of 200 – 300 nm, A) MCN and B) HCA following the addition 
of acid and alkali indicating robustness of the analytical method 
 
Table 3: Assay results of physical mixture and commercial brand of MCN and HCA using UV-visible 
















Miconazole 0.8055 ±0.02 102.26 ±1.76 101.39 ±1.01 
Hydrocortisone 0.2300 ±0.011 99.64 ± 0.98 100.43 ±0.97 
Physical 
Mixture 
Miconazole 0.7877 ±0.027 100.26 ±1.04 101.39 ±0.99 
Hydrocortisone 0.2308 ±0.009 100.64 ±1.1 100.43 ±1.05 
 
Assay results for commercial cream 
product 
 
The validity of the developed method was 
assessed by performing the assay on the 
physical mixture (20 and 10 mg MCN and HCA, 
respectively) and on commercially available 
cream (labeled claim 2 and 1 % MCN and HCA, 
respectively). The results are shown in table 4. 
The results obtained by UV spectroscopic 
analysis were further compared with the already 





Various researchers have proposed different 
methods for the determination of miconazole 
nitrate (MCN) and hydrocortisone acetate 
(HCNA) separately or in combination with some 
other drugs [21] in various dosage forms using 
varieties of analytical techniques. However, 
literature survey has shown that no analytical 
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method based on the simultaneous analysis of 
MCN and HCA by UV spectroscopic method has 
been reported previously. In comparison to other 
techniques, UV analyses are often preferred in 
quality control testing in a pharmaceutical 
industry where faster, robust and easily 
performing methods are required at the in 
process and finished stage of pharmaceutical 
dosage form. The objective of this study was to 
develop and validate a simpler and reliable UV-
spectrophotometric method for the simultaneous 
determination of MCN and HCA in 
pharmaceutical dosage form. The proposed 
method in this study has exhibited precise, 
accurate and robust assay for concomitant 
determination of MCN and HCA in physical 
mixture as well as in formulated creams. 
Furthermore the results have also shown that the 
proposed method is comparable with already 
available HPLC method in respect of sensitivity 
and recovery of active pharmaceutical ingredient.  
The wavelengths showing maximum absorbance 
(λmax) i.e. 205 and 249 nm for MCN and HCA, 
respectively were well resolved and showed no 
interference this shows the developed method is 
selective for both drugs. The calibration curves 
were found linear for the single and binary 
solution of MCN and HCA in the range 1 to 12 
µg/mL and 1 to 40 µg/mL, respectively. In case 
of binary solutions, other parameters of line 
equations describing the linear function i.e. slope 
and intercept showed an increase in their values 
from 0.0639 to 0.1394 and 0.0103 to 0.1095, 
respectively for MCN. One may argue that such 
increments in the absorbance are the 
consequence of contribution from the HCN; the 
linear behavior recorded from the absorbance 
data might be satisfactory to estimate the 
concentration of MCN. The absorbance data of 
hydrocortisone in binary solution, on the other 
hand, differ slightly from the test solution only in 
terms of its intercept value; the former being 
elevated from 0.219 to 0.2523. In response to the 
sensitivity of the developed method the results of 
LOD and LOQ shows that the proposed method 
is sensitive for both drugs and can easily quantify 
minimum concentration of 1.49 µg/mL for MCN 
and 4.57 µg/mL for HCA. The percentage 
recovery (accuracy) results for both drugs were 
in the range of 99 to 102 % showing a 
comparative accuracy as compare to HPLC 
method. The precision of proposed analytical 
procedure was determined in terms of intra-day 
precision (repeatability), inter-day precision 
(intermediate precision) and precision between 
laboratories (reproducibility). These studies were 
performed at three levels of drug concentrations 
(i.e. 6, 8, 10 µg/mL and 5, 10, 15 µg/mL for MCN 
and HCA, respectively). The RSD values 
obtained from all of these experiments were 
found within the range with maximum RSD value 
of 1.97 %. 
  
Robustness of the method can be described by 
the response of develop method with slight 
changes in temperature and pH. Our results has 
shown that he prescribed method is robust for 
analysis of both drugs in response to thermal 
changes and slight decrease in pH. However, in 
case of MCN, bathochromic shift was observed 
at higher pH conditions (i.e. 0.1 N NaOH). This 
might be due to the ionization of MCN at higher 
pH. Therefore one should ensure a minimum 
increase in the pH while using this method.  
 
The developed simultaneous method was also 
assessed for its validity by performing assay on 
physical mixture of the drugs as well as on 
commercially available cream. The results show 
that the method was successfully employed on 
these samples. Furthermore, these results are 




Based on the requirements of International 
Conference of Harmonization (ICH), the 
developed method is accurate, precise, robust, 
reliable and an alternate method for the 
simultaneous analysis of miconaole (MCN) and 
hydrocortisone (HCA) in pharmaceutical dosage 
forms. Furthermore, there is no need for any 
special pre-treatment of the sample for analysis. 
Compared to a previously reported HPLC 
method for the simultaneous quantification of 
these drugs, the present method is cost-effective, 
less time-consuming, and no special expertise is 
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